Redmile Group, LLC Xeris Biopharma Holdings, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,046,587 shares of XERS stock, worth $3.52 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,046,587
Previous 1,046,587
-0.0%
Holding current value
$3.52 Million
Previous $2.31 Million
1.82%
% of portfolio
0.15%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
134Shares Held
56.4MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$34.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.66MShares$25.7 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.2 Million61.49% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.83MShares$16.2 Million1.75% of portfolio
-
State Street Corp Boston, MA3.26MShares$10.9 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $457M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...